State Ledger
Company profile

REVIVA PHARMACEUTICALS HOLDINGS, INC. CIK 1742927

Ticker
RVPH (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Cupertino, CA 95014
Fiscal year end
2025 (FY)
Market Data
Close
$0.36
Change
+$0.00
Change %
0.00%
Volume
0

RVPH · trading date Oct 9, 2026 · previous close $0.36 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$19.86M
Total assets
$15.92M
Total liabilities
$7.28M
Stockholders' equity
$8.65M
Cash & equivalents
$14.44M
Operating income
-$20.20M
Operating cash flow
-$24.59M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
45.7%
Equity / assets
54.3%
CapEx / revenue
—
Operating cash flow / net income
1.24×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$19.86M $15.92M $7.28M $8.65M
2024 — -$29.92M $15.50M $14.69M $812.6K
2023 — -$39.26M $23.70M $17.98M $5.72M
2022 — -$28.26M $18.92M $10.53M $8.39M
2021 — -$8.52M $31.40M $2.72M $28.69M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G/A
2026-08-13
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cupertino, CA 95014
10080 N WOLFE ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies